Browsing by Author "Prabhat Kumar Saha"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
PublicationReview Compulsory licence for diabetes drug: Legality of Lee Pharma's application(Economic and Political Weekly, 2016) B.N. Pandey; Prabhat Kumar SahaThis article examines the legality of the Indian pharmaceutical company Lee Pharma's application for compulsory licence for Saxagliptin (Onglyza and Kombiglyze), an anti-diabetes drug, the patent for which is held by the Swedish multinational company AstraZeneca. What are the merits of the prima facie view taken by the controller of patents and the possibility of Lee Pharma getting the licence under the Indian patents law?PublicationReview Natco-Bayer verdict: Decoding local working requirement(Economic and Political Weekly, 2016) B.N. Pandey; Prabhat Kumar SahaBayer has lost its case challenging the grant of India's first-ever compulsory licence to Natco Pharma to manufacture an affordable generic version of an anti-cancer drug, but the celebratory air has to be tempered. The issue of what constitutes "local working" of a patent in India remains, in general, unsettled. This article looks at the legality of local working requirements under the Agreement on Trade-related Aspects of Intellectual Property Rights. It also analyses the interpretations of "working" by the Controller General of Patents, Designs and Trademarks, the Intellectual Property Appellate Board, and the Bombay High Court, and considers their broader implications.PublicationArticle Patents (Amendment) Rules 2020: India's patent working requirement at stake(Oxford University Press, 2021) Prabhat Kumar Saha; Shivam Kaushik[No abstract available]